Form 4 for BIAF bioAffinity Technologies, Inc.
Accepted 2024-01-24 00:00:00 ET · period of report 2024-01-01 · accession 0001493152-24-003694 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-24 | 2024-01-01 | BIAF | Platt Jamie | Dir | A - Grant | $1.48 | +12.7K | 12.7K | New | +$18.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-01 | A | A | 12,668 | $1.48 | 12,668 | D | — | — | (F1) Represents a grant from the Issuer to Ms. Platt of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year. |